Search research articles
Contact Us
Filters
Showing results (11-20 of 91) with videos related to
Page
of 10
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 25, 2016
appendix 8: Prostate cancer: eUpdate published online September 2016 (http://www.esmo.org/Guidelines/Genitourinary-Cancers)
C Parker, S Gillessen, A Horwich, et al.
Onkologie
|
February 5, 2003
The proteasome, a new target for cancer therapy
S Gillessen, M Groettup, T Cerny
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 26, 2009
'Sunitinib withdrawal phenomenon' or spontaneous regression in renal cell cancer
C A Rothermundt, A Omlin, S Gillessen
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 11, 2008
Remission of diabetes while on sunitinib treatment for renal cell carcinoma
A Templeton, M Brändle, T Cerny, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 24, 2016
Reply to the letter to the editor 'Many men with castrate-sensitive metastatic prostate cancer should not receive chemotherapy' by Tannock et al
C Parker, S Gillessen, A Heidenreich, et al.
European Urology
|
April 26, 2022
Reply to Yu Wei, Yao Zhu, and Dingwei Ye's Letter to the Editor re: Fabio Turco, Andrew Armstrong, Gerhardt Attard, et al. What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021. Eur Urol. 2022;82:6-11
F Turco, M Smith, A Omlin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 25, 2015
Cancer of the prostate: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
C Parker, S Gillessen, A Heidenreich, et al.
Onkologie
|
February 5, 2003
Postradiation high-grade myofibroblastic sarcoma of the prostate -- a rare entity of prostatic tumors -- responding to liposomal Doxorubicin
M Joerger, C Oehlschlegel, T Cerny, et al.
Blood
|
February 13, 2001
Overlapping roles for granulocyte-macrophage colony-stimulating factor and interleukin-3 in eosinophil homeostasis and contact hypersensitivity
S Gillessen, N Mach, C Small, et al.
Cancer Treatment Reviews
|
October 23, 2021
A systematic review of phase II trials exploring anti-PD-1/PD-L1 combinations in patients with solid tumors
F Martorana, I Colombo, G Treglia, et al.
Page
of 10
Search research articles
Search
Showing results (11-20 of 91) with videos related to
Sort By:
Page
of 10
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 25, 2016
appendix 8: Prostate cancer: eUpdate published online September 2016 (http://www.esmo.org/Guidelines/Genitourinary-Cancers)
C Parker, S Gillessen, A Horwich, et al.
Onkologie
|
February 5, 2003
The proteasome, a new target for cancer therapy
S Gillessen, M Groettup, T Cerny
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 26, 2009
'Sunitinib withdrawal phenomenon' or spontaneous regression in renal cell cancer
C A Rothermundt, A Omlin, S Gillessen
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 11, 2008
Remission of diabetes while on sunitinib treatment for renal cell carcinoma
A Templeton, M Brändle, T Cerny, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 24, 2016
Reply to the letter to the editor 'Many men with castrate-sensitive metastatic prostate cancer should not receive chemotherapy' by Tannock et al
C Parker, S Gillessen, A Heidenreich, et al.
European Urology
|
April 26, 2022
Reply to Yu Wei, Yao Zhu, and Dingwei Ye's Letter to the Editor re: Fabio Turco, Andrew Armstrong, Gerhardt Attard, et al. What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021. Eur Urol. 2022;82:6-11
F Turco, M Smith, A Omlin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 25, 2015
Cancer of the prostate: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
C Parker, S Gillessen, A Heidenreich, et al.
Onkologie
|
February 5, 2003
Postradiation high-grade myofibroblastic sarcoma of the prostate -- a rare entity of prostatic tumors -- responding to liposomal Doxorubicin
M Joerger, C Oehlschlegel, T Cerny, et al.
Blood
|
February 13, 2001
Overlapping roles for granulocyte-macrophage colony-stimulating factor and interleukin-3 in eosinophil homeostasis and contact hypersensitivity
S Gillessen, N Mach, C Small, et al.
Cancer Treatment Reviews
|
October 23, 2021
A systematic review of phase II trials exploring anti-PD-1/PD-L1 combinations in patients with solid tumors
F Martorana, I Colombo, G Treglia, et al.
Page
of 10